In this week's PEOPLE cover story, Denise Richards opens up about her daughter Eloise, and the blessings and challenges she's ...

Gene editing techniques may one day allow for the removal of the extra chromosome that causes Down syndrome, early ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...

Google has unveiled an AI co-scientist built on its Gemini 2.0 platform, aiming to accelerate scientific research by ...

I am inundated with Instagram ads telling me that “ADHD is not laziness, it’s a trauma response.” Well actually, it's neither ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month data on the first three adult OPGx-LCA5 patients to be pr ...

The Life-Changing Benefits of Early PCOS Treatment! - New Delhi [India],1: PCOS affects approximately 11.33% of Indian women, ...

Recent studies have identified nutrients in some foods that assist the brain in the production of good sleep. Studies have ...

Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the ...

Keeping kids healthy can be a big job. From the day their children are born, parents ferry them to and from medical offices, ...

Ambrosia Biosciences Inc., a drug-discovery company launched last year, has added Jason Haddock, a former executive with ArcherDX Inc. and Array BioPharma Inc., to its board of directors.

Sen. Brandon Shippy brought the bill and presented it with a slate of out-of-state physicians, many of whom have been linked ...